← Eichor
Condition: Rheumatoid Arthritis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Rheumatoid Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dysphagia in Rheumatoid Arthritis
Phase N/A · 2 location(s) · Tanta University · NCT07401732Pharmacogenetics of Leflunomide in the Management of Rheumatoid Arthritis
Phase N/A · 2 location(s) · Foundation University Islamabad · NCT07388407Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, a
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT03510442Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Sy
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT05927688Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arth
NA · 1 location(s) · Jérôme Bouchan · NCT07469540The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis
NA · 1 location(s) · Saglik Bilimleri Universitesi · NCT07320846Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
Phase N/A · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06771427The ATtune Knee Outcome Study
Phase N/A · 1 location(s) · Spaarne Gasthuis · NCT04247672Dose Response of Exercise for Arthritis Management
NA · 1 location(s) · University of South Carolina · NCT06880653Fecal Microbial Transplantation for Rheumatoid Arthritis Trial
NA · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05790356A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RE
Phase 2 · 6 location(s) · Lubris Bio Pty Ltd · NCT07118241Clinical Outcomes Study of the Nexel Total Elbow
NA · 11 location(s) · Zimmer Biomet · NCT02469662Ultra-High Frequency Ultrasonography in Sjögren's Syndrome
NA · 1 location(s) · University of Pisa · NCT06338735A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07517250Dynamic Treatment Regiments for Glucocorticoid Tapering
Phase 2 · 2 location(s) · VA Office of Research and Development · NCT06072768Rheumatoid Arthritis Remission Screening and Prospective Surveillance
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07571993Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel
EARLY_Phase 1 · 1 location(s) · Changhai Hospital · NCT07246096Effect of MTX Discontinuation on Shingrix Response in RA
NA · 1 location(s) · Konkuk University Medical Center · NCT06574594Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
Phase N/A · 2 location(s) · Exactech · NCT05619588Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Phase 2 · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT07281456Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Peking University Third Hospital · NCT06828042Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis
NA · 5 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06301373Biobank for Inflammatory Chronic Diseases and Osteoporosis
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05039216Belimumab After Rituximab in Resistant Primary Juvenile SS
Phase 4 · 1 location(s) · Peking Union Medical College Hospital · NCT06410833Study of GS-0151 in Participants With Rheumatoid Arthritis
Phase 1 · 35 location(s) · Gilead Sciences · NCT06902519Oxidative Stress in Autoimmune Rheumatic Diseases
Phase N/A · 1 location(s) · University of Thessaly · NCT07536529Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Phase 3 · 28 location(s) · Vor Biopharma · NCT07404865RA-PRO PRAGMATIC TRIAL
Phase 3 · 49 location(s) · University of Alabama at Birmingham · NCT04692493A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants Wit
Phase 1 · 37 location(s) · AstraZeneca · NCT06916806The Triad of Nutrition, Intestinal Microbiota and Rheumatoid Arthritis (TASTY)
NA · 2 location(s) · Lisbon Academic Medical Center - Centro Académico de Medicin · NCT06758817
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.